By Michael Erman, Bhanvi Satija and Patrick Wingrove NEW YORK/LONDON, Nov 20 (Reuters) – Artificial intelligence has sped up early-stage drug development work at some of the world's largest
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Sarah Morland MEXICO CITY, Nov 20 (Reuters) - EU agriculture commissioner Christophe Hansen expects…
(Recasts and updates with details) FRANKFURT, Nov 20 (Reuters) - Commerzbank CEO Bettina Orlopp on…
VIDEO SHOWS: REAL MADRID HOLDING TRAINING SESSION, COACH JOSE MOURINHO SPEAKING AT PRESS CONFERENCE AHEAD…
Nov 20 (Reuters) - Wacom Co Ltd: * WACOM: TO CONDUCT MANAGEMENT BUYOUT * WACOM:…
By Karl Plume CHICAGO, Nov 20 (Reuters) - US President Donald Trump visited Asia this…
By Anirban Sen NEW YORK, Nov 19 (Reuters) - The market share battle between the…